We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ORGS market cap is 10.91M. The company's latest EPS is USD -10.7097 and P/E is -0.20.
| Quarter End | Mar 2023 | Jun 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.04M | 6.98M | 141k | 246k | 347k |
| Operating Income | -3.21M | -3.33M | -8.93M | -4.25M | -8.39M |
| Net Income | -4.19M | -4.13M | -9.77M | -8.9M | -9.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 33.48M | 7.76M | 37.78M | 36.03M | 530k |
| Operating Income | -24.6M | -95.68M | -14.52M | -8.6M | -52.94M |
| Net Income | -24.12M | -94.6M | -18.05M | -14.89M | -55.36M |
| Quarter End | Mar 2023 | Jun 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 93.27M | 54.77M | 30.92M | 30.58M | 29.69M |
| Total Liabilities | 33.96M | 30.8M | 58.47M | 46.37M | 53.62M |
| Total Equity | 29M | 23.97M | -27.55M | -15.79M | -23.93M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 92.5M | 77.68M | 59.84M | 90.93M | 14.55M |
| Total Liabilities | 55.46M | 24.96M | 21.21M | 31.65M | 35.54M |
| Total Equity | 6.08M | 52.73M | 38.63M | 29.07M | -20.98M |
| Quarter End | Mar 2023 | Jun 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.24M | -13.15M | -4.44M | -10.35M | -14.98M |
| Investing | -1.31M | -2.8M | -68k | -69k | 73k |
| Financing | 5.91M | 10.8M | 3.61M | 10.13M | 14.56M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.22M | -78.05M | -26.87M | -24.92M | -14.84M |
| Investing | -13.78M | 105.61M | -12.38M | -14.13M | -3.71M |
| Financing | 24.1M | 5.88M | -106k | 39.58M | 13.62M |
| Market Cap | 10.91M |
| Price to Earnings Ratio | -0.20 |
| Price to Sales Ratio | 20.59 |
| Price to Cash Ratio | 13.03 |
| Price to Book Ratio | -0.52 |
| Dividend Yield | - |
| Shares Outstanding | 5.17M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -50.93% |
| 52 Week High | 10.799 |
| 52 Week Low | 1.9283 |
| Spread (Intraday) | 0.18 (8.18%) |
| Company Name | Orgenesis Inc |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https://orgenesis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
